Human papillomavirus genotypes and cervical cancer in Northeast Thailand

Asian Pacific Journal of Cancer Prevention

Volumn 14, Issue 11, 2013, Pages 6961-6964

  Natphopsuk, Sitakan ^a   Settheetham Ishida, Wannapa ^a   Pientong, Chamsai ^a   Sinawat, Supat ^a   Yuenyao, Pissamai ^a   Ishida, Takafumi ^b   Settheetham, Dariwan ^c  

^a Surin Hospital   (Thailand)

^b UNIVERSITY OF TOKYO   (Japan)

^c KHON KAEN UNIVERSITY   (Thailand)

Author keywords

Cervical cancer; Hpv genotype; Hpv prevalence; Northeast Thailand

Indexed keywords

VIRUS DNA;

ADULT; AGED; ARTICLE; CANCER STAGING; CASE CONTROL STUDY; COMPARATIVE STUDY; FEMALE; FOLLOW UP; GENETICS; GENOTYPE; HUMAN; METABOLISM; MIDDLE AGED; PAPILLOMA VIRUS; PAPILLOMAVIRUS INFECTION; PATHOLOGY; POLYMERASE CHAIN REACTION; PREVALENCE; PROGNOSIS; RISK FACTOR; SQUAMOUS CELL CARCINOMA; THAILAND; UTERINE CERVIX; UTERINE CERVIX TUMOR; VAGINA SMEAR; VERY ELDERLY; VIROLOGY;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; CERVIX UTERI; DNA, VIRAL; FEMALE; FOLLOW-UP STUDIES; GENOTYPE; HUMANS; MIDDLE AGED; NEOPLASM STAGING; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; PREVALENCE; PROGNOSIS; RISK FACTORS; THAILAND; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 84892469179     PISSN: 15137368     EISSN: None     Source Type: Journal    
DOI: 10.7314/APJCP.2013.14.11.6961     Document Type: Article

References (33)

1. Bhatla N, Lal N, Bao YP, Ng T, Qiao YL (2008). A meta-analysis of human papillomavirus type-distribution in women from South Asia: implications for vaccination. Vaccine, 26, 2811-7.
2. Camargo M, Soto-De Leon S, Sanchez R, et al (2011). Detection by PCR of human papillomavirus in Colombia: Comparison of GP5+/6+ and MY09/11 primer sets. J Virol Methods, 178, 68-74.
3. Chan PK, Cheung JL, Cheung TH, et al (2007). HLA-DQB1 polymorphisms and risk for cervical cancer: a case-control study in a southern Chinese population. Gynecol Oncol, 105, 736-41.
4. Chansaenroj J, Lurchachaiwong W, Termrungruanglert W, et al (2010). Prevalence and genotypes of human papillomavirus among Thai women. Asian Pac J Cancer Prev, 11, 117-22.
5. Chichareon S, Herrero R, Munoz N, et al (1998). Risk factors for cervical cancer in Thailand: a case-control study. J Natl Cancer Inst, 90, 50-7.
6. Chinchai T, Chansaenroj J, Swangvaree S, Junyangdikul P, Poovorawan Y (2012). Prevalence of human papillomavirus genotypes in cervical cancer. Int J Gynecol Cancer, 22, 1063-8.
7. de Sanjose S, Diaz M, Castellsague X, et al (2007). Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis. Lancet Infect Dis, 7, 453-9.
8. Domingo EJ, Noviani R, Noor MR, et al (2008). Epidemiology and prevention of cervical cancer in Indonesia, Malaysia, the Philippines, Thailand and Vietnam. Vaccine, 26, 71-9.
9. Ferlay J, Shin HR, Bray F, et al (2010). Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer, 127, 2893-917.
10. Goldsmith DB, West TM, Morton R (2002). HLA associations with nasopharyngeal carcinoma in Southern Chinese: a metaanalysis. Clin Otolaryngol Allied Sci, 27, 61-7.
11. Huang LW, Chao SL, Chen PH, Chou HP (2004). Multiple HPV genotypes in cervical carcinomas: improved DNA detection and typing in archival tissues. J Clin Virol, 29, 271-6.
12. Huang S, Afonina I, Miller BA, Beckmann AM (1997). Human papillomavirus types 52 and 58 are prevalent in cervical cancers from Chinese women. Int J Cancer, 70, 408-11.
13. Kawana K, Adachi K, Kojima S, Kozuma S, Fujii T (2012). Therapeutic Human papillomavirus (HPV) Vaccines: a novel approach. Open Virol J, 6, 264-9.
14. Konno R, Shin HR, Kim YT, et al (2008). Human papillomavirus infection and cervical cancer prevention in Japan and Korea. Vaccine, 26, 30-42.
15. Liaw KL, Hildesheim A, Burk RD, et al (2001). A prospective study of human papillomavirus (HPV) type 16 DNA detection by polymerase chain reaction and its association with acquisition and persistence of other HPV types. J Infect Dis, 183, 8-15.
16. Lurchachaiwong W, Junyangdikul P, Payungporn S, et al (2011). Human papillomavirus genotypes among infected Thai women with different cytological findings by analysis of E1 genes. New Microbiol, 34, 147-56.
17. National Cancer Institute (2012). Hospital-based cancer registry 2011. Bangkok.
18. Romphruk AV, Puapairoj C, Romphruk A, et al (1999). Distributions of HLA-DRB1/DQB1 alleles and haplotypes in the north-eastern Thai population: indicative of a distinct Thai population with Chinese admixtures in the central Thais. Eur J Immunogenet, 26, 129-33.
19. Romphruk AV, Romphruk A, Kongmaroeng C, et al (2010). HLA class I and II alleles and haplotypes in ethnic Northeast Thais. Tissue Antigens, 75, 701-11.
20. Serrano B, Alemany L, Tous S, et al (2012). Potential impact of a nine-valent vaccine in human papillomavirus related cervical disease. Infect Agent Cancer, 7, 38.
21. Settheetham-Ishida W, Kanjanavirojkul N, Kularbkaew C, Ishida T (2005). Human papillomavirus genotypes and the p53 codon 72 polymorphism in cervical cancer of Northeastern Thailand. Microbiol Immunol, 49, 417-21.
22. Shi JF, Qiao YL, Smith JS, et al (2008). Epidemiology and prevention of human papillomavirus and cervical cancer in China and Mongolia. Vaccine, 26, 53-9.
23. Siriaunkgul S, Suwiwat S, Settakorn J, et al (2008). HPV genotyping in cervical cancer in Northern Thailand: adapting the linear array HPV assay for use on paraffin-embedded tissue. Gynecol Oncol, 108, 555-60.
24. Sonoda S (1990). Genetic and immunologic determinants of HTLV-I-associated diseases. In human retrovirology: HTLV. New York W.A. Raven Press, Ltd.
25. Sriamporn S, Snijders PJ, Pientong C, et al (2006). Human papillomavirus and cervical cancer from a prospective study in Khon Kaen, Northeast Thailand. Int J Gynecol Cancer, 16, 266-9.
26. Sukvirach S, Smith JS, Tunsakul S, et al (2003). Populationbased human papillomavirus prevalence in Lampang and Songkla, Thailand. J Infect Dis, 187, 1246-56.
27. Suthipintawong C, Siriaunkgul S, Tungsinmunkong K, et al (2011). Human papilloma virus prevalence, genotype distribution, and pattern of infection in Thai women. Asian Pac J Cancer Prev, 12, 853-6.
28. Tay SK, Ngan HY, Chu TY, Cheung AN, Tay EH (2008). Epidemiology of human papillomavirus infection and cervical cancer and future perspectives in Hong Kong, Singapore and Taiwan. Vaccine, 26, 60-70.
29. Tungsinmunkong K, Suwiwat S, Sriplung H (2006). Detection of human papillomavirus in intraepithelial lesions and carcinoma of the cervix uteri in southern Thai women. Asian Pac J Cancer Prev, 7, 427-30.
30. van den Brule AJ, Pol R, Fransen-Daalmeijer N, et al (2002). GP5+/6+ PCR followed by reverse line blot analysis enables rapid and high-throughput identification of human papillomavirus genotypes. J Clin Microbiol, 40, 779-87.
31. Villa LL (2006). Prophylactic HPV vaccines: reducing the burden of HPV-related diseases. Vaccine, 24, 23-8.
32. Xue Y, Lim D, Zhi L, et al (2012). Loss of HPV16 E2 protein expression without disruption of the E2 ORF correlates with carcinogenic progression. Open Virol J, 6, 163-72.
33. Yue Y, Yang H, Wu K, et al (2013). Genetic variability in L1 and L2 genes of HPV-16 and HPV-58 in Southwest China. PLoS One, 8, 55204.